1. Home
  2. TBPH vs YEXT Comparison

TBPH vs YEXT Comparison

Compare TBPH & YEXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$20.04

Market Cap

993.7M

Sector

Health Care

ML Signal

HOLD

Logo Yext Inc.

YEXT

Yext Inc.

HOLD

Current Price

$7.59

Market Cap

981.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBPH
YEXT
Founded
2013
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
993.7M
981.0M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
TBPH
YEXT
Price
$20.04
$7.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$27.80
$9.44
AVG Volume (30 Days)
439.2K
862.7K
Earning Date
02-25-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.58
0.00
Revenue
$80,327,000.00
$447,666,000.00
Revenue This Year
$70.78
$8.66
Revenue Next Year
N/A
$4.77
P/E Ratio
$34.48
$35.37
Revenue Growth
27.12
9.46
52 Week Low
$7.90
$5.51
52 Week High
$20.79
$9.20

Technical Indicators

Market Signals
Indicator
TBPH
YEXT
Relative Strength Index (RSI) 62.84 30.84
Support Level $18.41 $7.77
Resistance Level $20.79 $7.79
Average True Range (ATR) 0.71 0.17
MACD 0.12 -0.05
Stochastic Oscillator 76.62 22.22

Price Performance

Historical Comparison
TBPH
YEXT

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About YEXT Yext Inc.

Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.

Share on Social Networks: